ACTISITE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Actisite, and when can generic versions of Actisite launch?
Actisite is a drug marketed by Schiff And Co and is included in one NDA.
The generic ingredient in ACTISITE is tetracycline hydrochloride. There is one drug master file entry for this compound. Ten suppliers are listed for this compound. Additional details are available on the tetracycline hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Actisite
A generic version of ACTISITE was approved as tetracycline hydrochloride by WATSON LABS on December 31st, 1969.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ACTISITE?
- What are the global sales for ACTISITE?
- What is Average Wholesale Price for ACTISITE?
Summary for ACTISITE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 77 |
| Patent Applications: | 4,069 |
| DailyMed Link: | ACTISITE at DailyMed |
US Patents and Regulatory Information for ACTISITE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schiff And Co | ACTISITE | tetracycline hydrochloride | FIBER, EXTENDED RELEASE;PERIODONTAL | 050653-001 | Mar 25, 1994 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
